Author

Priya Solanki

Indian Institute of Technology JodhpurORCID 0009-0005-3324-8154Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Durgesh MeenaiD· 2 shared Shalini ChhipaiD· 2 shared Sushmita JhaiD· 2 shared Deepak KumariD· 1 shared Divya Shivakumar· 1 shared Jaskaran Singh GosaliD· 1 shared Lipika ShaiD· 1 shared M.S. Revanth· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Durgesh MeenaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyJournal of Cellular PhysiologyPeer-reviewedMar 1, 2026

Innate Immune Receptor NLRX1: Potential Modulator of Glioblastoma Pathophysiology

Durgesh Meena, Divya Shivakumar, Sushmita Rajkhowa…·Sushmita Jha

This study shows NLRX1 modulates glioblastoma cell proliferation, migration, and metabolism by affecting autophagy and tunneling nanotubes.

6 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintNov 11, 2025

Repurposing Nelfinavir: AIM2 Inflammasome-Driven Anti-tumor Effects in Glioblastoma

Durgesh Meena, Shalini Chhipa, Priya Solanki…·Sushmita Jha

This study investigates Nelfinavir's anti-tumor effects in Glioblastoma, showing it inhibits proliferation and induces cell death via AIM2 inflammasome activation.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky